DK3476395T3 - Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme - Google Patents
Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme Download PDFInfo
- Publication number
- DK3476395T3 DK3476395T3 DK18758465.1T DK18758465T DK3476395T3 DK 3476395 T3 DK3476395 T3 DK 3476395T3 DK 18758465 T DK18758465 T DK 18758465T DK 3476395 T3 DK3476395 T3 DK 3476395T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- composition including
- heart diseases
- including fibroblasts
- injectible composition
- Prior art date
Links
- 210000002950 fibroblast Anatomy 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017033624 | 2017-02-24 | ||
| PCT/JP2018/006795 WO2018155651A1 (ja) | 2017-02-24 | 2018-02-23 | 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3476395T3 true DK3476395T3 (da) | 2021-08-16 |
Family
ID=63253929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18758465.1T DK3476395T3 (da) | 2017-02-24 | 2018-02-23 | Injicerbar sammensætning omfattende fibroblaster til anvendelse i behandlingen af hjertesygdomme |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11096969B2 (enExample) |
| EP (1) | EP3476395B1 (enExample) |
| JP (2) | JP6618066B2 (enExample) |
| KR (1) | KR102407387B1 (enExample) |
| CN (1) | CN109890398B (enExample) |
| AU (1) | AU2018223739B2 (enExample) |
| CA (1) | CA3032654A1 (enExample) |
| DK (1) | DK3476395T3 (enExample) |
| ES (1) | ES2885080T3 (enExample) |
| IL (1) | IL267958B2 (enExample) |
| SG (1) | SG11201900810WA (enExample) |
| WO (1) | WO2018155651A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019332400B2 (en) * | 2018-08-29 | 2025-06-26 | Lymphogenix Limited | Method for producing fibroblast, and G-CSF-positive fibroblast mass |
| CN109589337B (zh) | 2018-12-29 | 2022-04-26 | 南京艾尔普再生医学科技有限公司 | 心肌细胞制剂及其制备方法和应用 |
| KR20220148184A (ko) | 2020-03-04 | 2022-11-04 | 가부시키가이샤 메토세라 | 에리트로포이에틴 산생능이 항진된 섬유 아세포 |
| IL305069A (en) * | 2021-03-04 | 2023-10-01 | Metcela Inc | Fibroblast beta-factor promotes lymphangiogenesis, and a pharmaceutical preparation containing it |
| CN117750964A (zh) * | 2021-09-08 | 2024-03-22 | 玛土撤拉有限公司 | 含有成纤维细胞的肾疾病治疗用医药组合物 |
| EP4249585A1 (en) * | 2022-03-25 | 2023-09-27 | Technische Universität München - TUM | Heart tissue models, method of producing heart tissue models and uses of heart tissue models |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| CN100435882C (zh) * | 2002-05-08 | 2008-11-26 | 加利福尼亚大学董事会 | 用成纤维细胞治疗心律失常的系统和方法 |
| WO2003095016A1 (en) * | 2002-05-08 | 2003-11-20 | The Regents Of The University Of California | System and method for forming a non-ablative cardiac conduction block |
| US20040161412A1 (en) * | 2002-08-22 | 2004-08-19 | The Cleveland Clinic Foundation | Cell-based VEGF delivery |
| US7470538B2 (en) * | 2002-12-05 | 2008-12-30 | Case Western Reserve University | Cell-based therapies for ischemia |
| CN101415458A (zh) * | 2003-11-10 | 2009-04-22 | 辛弗尼医药有限公司 | 控制心房纤维性颤动患者心室律的方法 |
| US8513011B2 (en) * | 2004-08-26 | 2013-08-20 | Biotech Research Ventures Pte Limited | Methods and compositions for culturing cardiomyocyte-like cells |
| ES2325715B1 (es) * | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
| JP5378743B2 (ja) | 2008-09-30 | 2013-12-25 | テルモ株式会社 | 医療用細胞シートの製造方法 |
| WO2013028968A1 (en) * | 2011-08-25 | 2013-02-28 | Wisconsin Alumni Research Foundation | 3-dimensional cardiac fibroblast derived extracellular matrix |
| EP2826855B1 (en) | 2012-03-15 | 2018-08-29 | iHeart Japan Corporation | Myocardial sheet |
| US20140072611A1 (en) * | 2012-09-07 | 2014-03-13 | Fibrocell Technologies, Inc. | Methods and Compositions for Treating Post-Cardial Infarction Damage |
| GB201309057D0 (en) | 2013-05-20 | 2013-07-03 | Cell Therapy Ltd | Method |
| KR20150009655A (ko) * | 2013-07-16 | 2015-01-27 | 학교법인 동아학숙 | Gcp-2 유전자를 과발현하는 지방 간엽줄기세포를 포함하는 허혈성 질환 치료용 조성물 |
| CN106661552B (zh) | 2014-07-11 | 2020-07-07 | 玛土撤拉有限公司 | 心脏细胞培养材料 |
-
2018
- 2018-02-23 WO PCT/JP2018/006795 patent/WO2018155651A1/ja not_active Ceased
- 2018-02-23 ES ES18758465T patent/ES2885080T3/es active Active
- 2018-02-23 JP JP2019501845A patent/JP6618066B2/ja active Active
- 2018-02-23 CN CN201880003050.1A patent/CN109890398B/zh active Active
- 2018-02-23 KR KR1020197003364A patent/KR102407387B1/ko active Active
- 2018-02-23 AU AU2018223739A patent/AU2018223739B2/en active Active
- 2018-02-23 DK DK18758465.1T patent/DK3476395T3/da active
- 2018-02-23 EP EP18758465.1A patent/EP3476395B1/en active Active
- 2018-02-23 CA CA3032654A patent/CA3032654A1/en active Pending
- 2018-02-23 SG SG11201900810WA patent/SG11201900810WA/en unknown
-
2019
- 2019-01-31 US US16/263,321 patent/US11096969B2/en active Active
- 2019-07-09 IL IL267958A patent/IL267958B2/en unknown
- 2019-10-03 JP JP2019182761A patent/JP7072135B2/ja active Active
-
2021
- 2021-07-19 US US17/379,671 patent/US20210346436A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018155651A1 (ja) | 2018-08-30 |
| KR20190117468A (ko) | 2019-10-16 |
| ES2885080T3 (es) | 2021-12-13 |
| JP7072135B2 (ja) | 2022-05-20 |
| EP3476395A1 (en) | 2019-05-01 |
| JPWO2018155651A1 (ja) | 2019-11-07 |
| CN109890398A (zh) | 2019-06-14 |
| CA3032654A1 (en) | 2018-08-30 |
| US20210346436A1 (en) | 2021-11-11 |
| IL267958B1 (en) | 2023-04-01 |
| US11096969B2 (en) | 2021-08-24 |
| CN109890398B (zh) | 2024-01-16 |
| IL267958A (en) | 2019-09-26 |
| SG11201900810WA (en) | 2019-02-27 |
| EP3476395B1 (en) | 2021-07-21 |
| KR102407387B1 (ko) | 2022-06-10 |
| AU2018223739A1 (en) | 2019-02-14 |
| AU2018223739B2 (en) | 2023-06-22 |
| IL267958B2 (en) | 2023-08-01 |
| JP6618066B2 (ja) | 2019-12-11 |
| US20190224250A1 (en) | 2019-07-25 |
| EP3476395A4 (en) | 2020-02-26 |
| JP2019218408A (ja) | 2019-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3359171C0 (en) | Use of akkermansia muciniphila for treating inflammatory conditions | |
| EP3383411C0 (en) | SUB-MITOCHONDRIAL PARTICLES FOR USE IN THE TREATMENT OF METABOLIC DISEASES | |
| EP3263132C0 (en) | COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IL-6 | |
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| EP3402486C0 (en) | CCX168 FOR USE IN THE TREATMENT OF C3 GLOMERULOPATHY | |
| EP3515420C0 (en) | PHARMACEUTICAL COMPOSITIONS FOR USE IN BLEPHARITIS THERAPY | |
| IL256166B (en) | Compounds for use in treating neuromuscular disorders | |
| EP3349783C0 (en) | COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES | |
| PL3377637T3 (pl) | Kompozycje do stosowania w sposobach leczenia ran, zaburzeń i chorób skóry | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| SI3346995T1 (sl) | Terapevtski sestavek za zdravljenje virusa človeške imunske pomanjkljivosti | |
| DK2945642T3 (da) | Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme | |
| PL3381451T3 (pl) | Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej | |
| ZA201902275B (en) | Topical dressing composition for the treatment of damaged skin tissue | |
| DK3710000T3 (da) | Tradipitant til anvendelse til behandling af gastroparese | |
| IL270978B (en) | Grape skin for use in the treatment of dysbiosis | |
| HRP20260406T1 (hr) | Lumateperon za primjenu u liječenju shizofrenije | |
| EP3185862A4 (en) | PROTECTIVE METALLOTHIONEIN ANALOGUES, THEIR COMPOSITIONS AND THEIR USE IN THE TREATMENT OF PATHOGENIC DISEASES | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| EP3303556C0 (en) | COMPOSITIONS FOR THE TREATMENT OF OSTEO-CARTILAGINOUS DISORDERS | |
| EP3773539A4 (en) | COMPOSITIONS FOR THE TREATMENT OF THE SKIN | |
| EP3395341C0 (en) | COMPOSITION FOR THE TREATMENT OF NEUROMOTOR DISEASES AND ITS USE | |
| DK3761982T3 (da) | Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii |